| Pharmaceutical active ingredients: |
| Niflumic Acid |
| Available forms, composition and doses of Niflugel: |
| Gel; Local; Niflumic Acid 2.5% |
| Niflugel medical category: |
| Human:Cyclooxygenase-2 inhibitorsJoint and muscular pain treatment drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX02 - Niflumic AcidM02AA17 - Niflumic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bristol-Myers SquibbUPSA LaboratoiresUpsamedica |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Niflan | Pranoprofen | Societa Industria Farmaceutica Italiana; Senju Pharmaceutical |
| Niflec | Macrogol 4000; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Sodium Sulfate | Meiji Indonesian Pharmaceutical Industries |
| Niflex | Ethoxyquin | Unidentified Pharmaceutical Company |
| Niflex D | Ethoxyquin | Unidentified Pharmaceutical Company |
| Niflucan | Flunarizine | Duncan Laboratorios |
| Nifluril | Niflumic Acid | Bristol-Myers Squibb; UPSA Laboratoires; Upsamedica; Wing Wai Trading |
| Nifluril Dental Gel | Hexetidine; Niflumic Acid Glycinamide | Bristol-Myers Squibb; UPSA Laboratoires |
| Nifluril Suppositories | Morniflumate | Bristol-Myers Squibb; UPSA Laboratoires; Upsamedica; Wing Wai Trading |
| Niflux | Carbocisteine; Sobrerol | Alodial Farmaceutica |
| Nifolin | Folic Acid | Unidentified Pharmaceutical Company |